T2AV-Compass: Towards Unified Evaluation for Text-to-Audio-Video Generation

Text-to-Audio-Video (T2AV) generation aims to synthesize temporally coherent video and semantically synchronized audio from natural language, yet its evaluation remains fragmented, often relying on unimodal metrics or narrowly scoped benchmarks that fail to capture cross-modal alignment, instruction following, and perceptual realism under complex prompts. To address this limitation, we present T2AV-Compass, a unified benchmark for comprehensive evaluation of T2AV systems, consisting of 500 diverse and complex prompts constructed via a taxonomy-driven pipeline to ensure semantic richness and physical plausibility. Besides, T2AV-Compass introduces a dual-level evaluation framework that integrates objective signal-level metrics for video quality, audio quality, and cross-modal alignment with a subjective MLLM-as-a-Judge protocol for instruction following and realism assessment. Extensive evaluation of 11 representative T2AVsystems reveals that even the strongest models fall substantially short of human-level realism and cross-modal consistency, with persistent failures in audio realism, fine-grained synchronization, instruction following, etc. These results indicate significant improvement room for future models and highlight the value of T2AV-Compass as a challenging and diagnostic testbed for advancing text-to-audio-video generation.

CTP-LLM: Clinical Trial Phase Transition Prediction Using Large Language Models

New medical treatment development requires multiple phases of clinical trials. Despite the significant human and financial costs of bringing a drug to market, less than 20% of drugs in testing will make it from the first phase to final approval. Recent literature indicates that the design of the trial protocols significantly contributes to trial performance. We investigated Clinical Trial Outcome Prediction (CTOP) using trial design documents to predict phase transitions automatically. We propose CTP-LLM, the first Large Language Model (LLM) based model for CTOP. We also introduce the PhaseTransition (PT) Dataset; which labels trials based on their progression through the regulatory process and serves as a benchmark for CTOP evaluation. Our fine-tuned GPT-3.5-based model (CTP-LLM) predicts clinical trial phase transition by analyzing the trial's original protocol texts without requiring human-selected features. CTP-LLM achieves a 67% accuracy rate in predicting trial phase transitions across all phases and a 75% accuracy rate specifically in predicting the transition from Phase~III to final approval. Our experimental performance highlights the potential of LLM-powered applications in forecasting clinical trial outcomes and assessing trial design.